Introduction
Fibroblasts synthesize, organize, and maintain connective tissues during development and in response to injury and fi brotic disease (Trinkaus, 1984; Tomasek et al., 2002; Desmouliere et al., 2004) . Cells cultured in three-dimensional (3D) collagen matrices have been used to study fi broblast-matrix interactions in a tissue-like environment. Fibroblast morphology in the 3D environment ranges from dendritic to stellate to bipolar, depending on matrix stiffness and tension (Cukierman et al., 2002; Grinnell, 2003) , which is similar to cells in tissues (Goldsmith et al., 2004; Langevin et al., 2005) and quite distinct from the fl attened morphology of fi broblasts on two-dimensional (2D) tissue culture surfaces.
Cells can exert mechanical force on their surroundings (Bershadsky et al., 2003; Ingber, 2003; Katsumi et al., 2004; Meshel et al., 2005) , and fi broblasts in 3D collagen matrices use this force to contract the matrix (Brown et al., 1998; Tomasek et al., 2002; Grinnell, 2003; Petroll and Ma, 2003; Vanni et al., 2003; Wakatsuki and Elson, 2003) . The mechanism by which fi broblasts regulate the contraction of 3D collagen matrices has been shown to vary according to growth factor stimulus, mechanical environment, and the differentiation state of the cells.
The physiological agonists PDGF and lysophosphatidic acid (LPA) both stimulate fl oating matrix contraction, even though these agonists have opposite effects on the movement of cellular dendritic extensions within the matrices. PDGF increases their protrusion; LPA causes their retraction .
Studies with C3 exotransferase showed that the small G protein Rho is required for fl oating matrix contraction by either PDGF or LPA , but only PDGFstimulated, and not LPA-stimulated, contraction was inhibited by blocking the Rho effector Rho kinase (Abe et al., 2003; Lee et al., 2003) . Therefore, PDGF and LPA regulate fl oating collagen matrix contraction, in part, by different signaling mechanisms, and it has remained an open question as to whether there is a point of convergence.
p21-activated kinases (PAKs) were fi rst identifi ed as Racand Cdc42-interacting proteins (Manser et al., 1994) and are now known to be important in the regulation of cytoskeletal organization and cell migration (Bokoch, 2003; Zhao and Manser, 2005) . Early on, PAK1 was recognized as a downstream effector for PDGF (Bokoch et al., 1996; Dharmawardhane et al., 1997) , but more recently was shown to also be important for LPA-mediated signaling (Menard and Mattingly, 2003; Jung et al., 2004) . In this study, we show that the PDGF and LPA signaling pathways that regulate matrix contraction converge on PAK1 and its downstream effector cofi lin and that contraction depends on cellular ruffl ing activity, rather than on P21-activated kinase 1: convergence point in PDGF-and LPA-stimulated collagen matrix contraction by human fi broblasts
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Department of Cell Biology, University of Texas Southwestern Medical School, Dallas, TX 75390 F ibroblast three-dimensional collagen matrix culture provides a tissue-like model that can be used to analyze cell form and function. The physiological agonists platelet-derived growth factor (PDGF) and lysophosphatidic acid (LPA) both stimulate human fi broblasts to contract fl oating collagen matrices. In this study, we show that the PDGF and LPA signaling pathways required for matrix contraction converge on p21-activated kinase 1 (PAK1) and its downstream effector cofi lin1 and that contraction depends on cellular ruffl ing activity, rather than on the protrusion and retraction of cellular dendritic extensions. We also show that, depending on the agonist, different Rho effectors cooperate with PAK1 to regulate matrix contraction, Rho kinase in the case of PDGF and mDia1 in the case of LPA. These fi ndings establish a unifi ed framework for understanding the cell signaling pathways involved in fi broblast contraction of fl oating collagen matrices. (A) Cells were transfected for 12 h with 700 nM siRNA or sense RNA only (Mock) and cultured for an additional 24 h in growth medium without siRNA. Extracts were prepared and subjected to SDS-PAGE and immunoblotted to analyze levels of PAK1, PAK2, and tubulin. (B) PAK1-silenced and mock-transfected cells were harvested and incubated for 1 h on collagencoated glass coverslips in DME containing 5 mg/ml BSA and 10 μM LPA or 50 ng/ml PDGF as indicated. At the end of the incubation, samples were fi xed and stained for actin. Bar, 50 μm. Figure 2 . Silencing PAK1 inhibits cell migration. (A) PAK1-silenced and mock-transfected cells were harvested and cultured overnight on collagencoated coverslips. After scrape wounding, the cultures were incubated in DME containing 5 mg/ml BSA and 50 ng/ml PDGF. At the end of the incubations, samples were fi xed and stained for actin. (B) Migration was quantifi ed by determining the average distance of cell migration from the wound edge based on measurement of 10 separate microscopic fi elds and 5 cells within each fi eld. Bar, 150 μm.
protrusion and retraction of cellular dendritic extensions. We also show that, depending on the agonist, different Rho effectors are required to cooperate with PAK1 to regulate matrix contraction, Rho kinase in the case of PDGF and mDia1 in the case of LPA.
Results

Effects of PAK1 silencing on fi broblast morphology and of migration on collagen-coated coverslips
We used small interfering RNA (siRNA) to knock down PAK1 expression in human fibroblasts. Fig. 1 A shows an example of immunoblot analysis performed on cell lysates prepared from cells after a 36-h transfection with PAK1-specifi c doublestranded siRNA. Levels of PAK1 in the PAK1 siRNA, but not in mock-transfected cells, were reduced by almost 95% without affecting levels of PAK2. Fig. 1 B shows the morphology of PAK1-silenced versus mock-transfected cells by fl uorescence visualization of actin. Compared with control cells, knocking down PAK1 had no detectable effect on cell spreading or response to PDGF and LPA in 2D culture. Treatment with PDGF caused the appearance of small lamellipodia along the cell margins, and treatment with LPA increased formation of actin stress fi bers.
Transfection studies with modifi ed PAK1 constructs have demonstrated a role for PAK1 in cell motility (Sells et al., 1999) . Consistent with this fi nding, human fi broblast migration was decreased by knocking down PAK1. Fig. 2 A shows the typical appearance of cultures that were scrape wounded and incubated in medium containing PDGF. During the initial 3-6 h of culture, both mock-transfected and PAK1 knockdown cells extended lamellipodia into the scrape region. By 24 h of incubation, however, PAK1 knockdown cells had migrated substantially further into the wound region compared with the controls. Fibroblasts within 3D collagen matrices protrude a dendritic network of extensions that expands in response to PDGF stimulation and retracts in response to LPA stimulation (Abe et al., 2003) . Fig. 3 (1 h) and Fig. 4 (4 h) show representative photomicrographs of the network under basal (BSA), expanded (PDGF), and retracted (LPA) conditions. Fibroblast dendritic extensions have microtubule cores (Figs. 3 and 4, green) with ruffl ing, actin-rich tips (red). Retraction of the extensions in response to LPA stimulation occurred within 1 h in PAK1-silenced Figure 3 . Dendritic extensions and ruffl ing by PAK1-silenced human fi broblasts incubated for 1 h in collagen matrices. (A) PAK1-silenced and mock-transfected cells were harvested and used to prepare fl oating collagen matrices. Samples were incubated for 1 h in DME containing 5 mg/ml BSA and 50 ng/ml PDGF or 10 μM LPA, as indicated. At the end of the incubations, samples were fi xed and stained with anti-tubulin antibody for microtubules and rhodamine-phalloidin for actin. (B) Enlarged view of dendritic extension tips in the boxed areas. Green, microtubules; red, actin. Bar, 20 μm. (A) PAK1-silenced and mock-transfected cells were harvested and used to prepare fl oating collagen matrices. Samples were incubated for 4 h in DME containing 5 mg/ml BSA and 50 ng/ml PDGF or 10 μM LPA, as indicated. At the end of the incubations, samples were fi xed and stained with anti-tubulin antibody for microtubules and rhodamine-phalloidin for actin. (B) Enlarged view of dendritic extension tips in the boxed areas. Green, micro tubules; red, actin. Bar, 20 μm.
or mock-transfected cells, after which most fi broblasts either were round or had short extensions. Expansion of the dendritic network in response to PDGF was reduced in PAK1 knockdown cells. Table I shows morphometric analysis of a representative experiment. After 4 h in basal-and PDGF-containing medium, the projected cell area, branch length, and number of branches were all lower in PAK1-silenced cells. Therefore, PAK1 played a role in regulation of fi broblast dendritic extensions, but formation of the extensions was PAK1 independent.
The actin-rich tips of fi broblast extensions (protruded or retracted) showed prominent ruffl ing activity. In general, ruffl ing was more evident in PDGF-and LPA-stimulated cells than in basal (BSA) medium, and Figs. 3 B and 4 B show that cell ruffl ing induced by PDGF or LPA was markedly reduced in PAK1-silenced cells, compared with mock-transfected cells. Therefore, PAK1 appeared to be necessary for cell ruffl ing, regardless of whether the cells were stimulated by PDGF or LPA.
Collagen matrix contraction experiments also were performed using PAK1-silenced and mock-transfected cells. Contraction was quantifi ed by measuring the diameter of collagen matrices before ‫21ف(‬ mm) and after contraction and then calculating the difference. Fig. 5 shows that after 4 h in the presence of LPA or PDGF, contraction was ‫7-6ف‬ mm for control cells and ‫2ف‬ mm for PAK1 knockdown cells. The latter value is comparable to the level of basal contraction without agonist stimulation. These fi ndings demonstrated that PAK1 was required for both PDGF-and LPA-stimulated matrix contraction.
Inhibiting phosphoinositide 3 (PI3) kinase selectively blocks PDGF-stimulated collagen matrix contraction and cell ruffl ing
Current studies suggested PAK1 as a potential point of convergence in PDGF and LPA regulation of cell ruffl ing and collagen matrix contraction. Activation of cell ruffl ing and PAK in response to PDGF stimulation depends on PI3 kinase (HooshmandRad et al., 1997; Sells et al., 2000) . In previous papers, the role of PI3 kinase in contraction of fl oating collagen matrices was tested, but the fi ndings were inconsistent (Ahlen et al., 1998; Skuta et al., 1999; Han et al., 2002) . In preliminary experiments, we established that 20 μM LY294002 inhibited PDGF-stimulated PI3 kinase activity based on measurement of Akt phosphorylation (unpublished data). Fig. 6 A demonstrates that this concentration of the PI3 kinase inhibitor (LY) blocked PDGF-stimulated, but not LPA-stimulated, matrix contraction. In addition, Fig. 6 B shows that blocking PI3 kinase inhibited PDGF-stimulated, but not LPA-stimulated, cell ruffl ing. Therefore, PI3 kinase was required for both cell ruffl ing and contraction stimulated by PDGF, whereas the link between LPA and PAK1 appeared to be PI3 kinase independent, as has been reported (Menard and Mattingly, 2003) .
Pertussis toxin treatment selectively blocks LPA-stimulated matrix contraction and cell ruffl ing
LPA receptors couple to multiple G protein signaling pathways (Anliker and Chun, 2004; Moolenaar et al., 2004) , and Gα i has been implicated in fl oating collagen matrix contraction . Fig. 7 A shows that overnight treatment with pertussis toxin inhibited LPA-stimulated, but not PDGF-stimulated, matrix contraction. In addition, Fig. 7 B shows that pertussis toxin treatment inhibited cell ruffl ing stimulated by LPA. These fi ndings provided evidence for a link between PAK1-dependent cell ruffl ing and contraction stimulated by LPA, which was distinct from PDGF.
Downstream role of cofi lin1 in PAK1-dependent collagen matrix contraction
The actin dynamics required for fi broblast ruffl ing can be controlled at the level of actin-depolymerizing factor (ADF)/cofi lin by the PAK1 effector LIM kinase (Arber et al., 1998; Yang et al., 1998; Bamburg, 1999; Edwards et al., 1999) . Fig. 8 A shows that with fi broblasts in 3D collagen matrices, PDGF and LPA stimulated cofi lin1 phosphorylation and that stimulation was inhibited in PAK1-silenced cells. Contraction experiments were performed after knocking down cofi lin1 using siRNA, which, as shown in Fig. 8 B, could be reduced by >70%. PAK1-silenced and mock-transfected cells were harvested and used to prepare fl oating collagen matrices. Samples were incubated for 4 h in DME containing 5 mg/ml BSA and 50 ng/ml PDGF, as indicated. At the end of the incubations, samples were fi xed and stained with rhodamine-phalloidin for actin. For each value, measurements were made on 50 cells that were photographed at random. Nontransfected (Control), PAK1-silenced, and mock-transfected cells were harvested and used to prepare fl oating collagen matrices. Samples were incubated for 4 h in DME with 5 mg/ml BSA and 50 ng/ml PDGF or 10 μM LPA added as shown. At the end of the incubations samples were fi xed and the extent of matrix contraction was measured as the decrease in matrix diameter. Data shown are arithmetic mean ± SD for three separate experiments.
activity (unpublished data). Therefore, it could be concluded that cofi lin1 was a downstream effector for PAK1 in LPA-and PDGF-stimulated collagen matrix contraction.
Different Rho effectors cooperate
with PAK1 to regulate LPA-and
PDGF-stimulated matrix contraction
Together, the experiments identifi ed PAK1 as a downstream convergence point for the regulation of both cell ruffl ing and collagen matrix contraction stimulated by PDGF and LPA. As already mentioned, PDGF-and LPA-dependent fl oating collagen matrix contraction requires activity of the small G protein Rho , but only PDGF-stimulated contraction was dependent on the Rho effector Rho kinase (Abe et al., 2003; Lee et al., 2003) . Consistent with this observation, Fig.  6 A shows that blocking Rho kinase (Y) inhibited PDGFdependent, but not LPA-dependent, contraction of fl oating collagen matrices. Moreover, blocking Rho kinase did not cause a decrease in cell ruffl ing (unpublished data). Therefore, rather than functioning in the same signaling pathway as PAK1, it seemed likely that PAK1 and Rho acted in parallel cooperative fashion. Along with Rho kinase, mDia1 has been implicated as a Rho effector for regulation of actin cytoskeletal dynamics and force generation (Watanabe et al., 1999; Geiger and Bershadsky, 2001 ). Therefore, we tested the possibility that mDia1 might be the Rho effector required for LPA-stimulated matrix contraction. This was accomplished by knocking down mDia1expression. Fig. 9 A shows that levels of mDia1 in mDia1-specifi c siRNA, but not in mock-transfected cells, were reduced by >95%. mDia1-silenced cells were able to spread on collagencoated coverslips and form vinculin-containing focal adhesions, although the cells were rounder and had reduced actin stress fi bers compared with controls (unpublished data), as has been reported (Watanabe and Higashida, 2004) . Fig. 9 B shows the results of collagen matrix contraction studies with mDia1-silenced and mock-transfected cells. Silencing mDia1 selectively inhibited LPA-stimulated contraction without affecting PDGF-stimulated contraction. However, knocking down mDia1 had no effect on cell ruffl ing (unpublished data). Therefore, different Rho effectors cooperated with PAK1 in fi broblast contraction of fl oating collagen matrices depending on the agonist used to stimulate contraction, which was Rho kinase in the case of PDGF and mDia1 in the case of LPA.
Control experiments were also performed to confi rm activation of mDia1 by LPA. This was accomplished by taking advantage of the observation that LPA-stimulated formation of stable (nocodazole-resistant) microtubules depends on mDia1 (Cook et al., 1998; Palazzo et al., 2001 ). Serum-starved mDia1-silenced and mock-transfected cells were agonist stimulated and tested for the development of nocodazole-resistant microtubules (Gundersen et al., 1994; Cook et al., 1998) . Fig. 9 C shows that after agonist stimulation by PDGF or LPA, a subpopulation of microtubules in mock-transfected cells became nocodazole resistant, but that in mDia1-silenced cells LPA was no longer able to stimulate formation of stable microtubules.
Discussion
Fig. 10 summarizes the results of our studies. We found that PDGF and LPA regulate fl oating collagen matrix contraction through signaling pathways that converge on PAK1 and its downstream effector, cofi lin, and that contraction depends on cellular ruffl ing activity. Moreover, different Rho effectors were observed to cooperate with PAK1 in regulating contraction, Rho kinase in the case of PDGF and mDia1 in the case of LPA.
Previous work (for review see Grinnell, 2003) had demonstrated that the physiological agonists LPA and PDGF stimulated fibroblast contraction of fl oating collagen matrices, but the relationship between the signaling mechanisms involved had not been elucidated. These agonists have opposite effects on the overall movement of fi broblast dendritic extensions: retraction in response to LPA and protrusion in response to PDGF . Moreover, blocking Rho kinase or myosin II activity was shown to inhibit PDGF-dependent, but not LPA-dependent, matrix contraction (Abe et al., 2003; Lee et al., 2003) .
PAK1 is a downstream effector for both PDGF- (Bokoch et al., 1996; Dharmawardhane et al., 1997) and LPA-mediated signaling (Menard and Mattingly, 2003; Jung et al., 2004) . Therefore, we analyzed the possible role of PAK1 in matrix contraction, using siRNA to silence PAK1 expression, and learned that knocking down PAK1 resulted in inhibition of contraction stimulated by either agonist.
Microinjection and expression studies had implicated PAK1 in ruffl ing and motility of cells on 2D surfaces (Dharmawardhane et al., 1997; Sells et al., 1997 Sells et al., , 1999 Sells et al., , 2000 . Although PDGF and LPA have opposite effects on the overall movement of fi broblast dendritic extensions, both agonists were found to stimulate membrane ruffl ing activity. However, ruffl ing by cells in 3D matrices was inhibited in PAK1-silenced cells. In addition, blocking PI3 kinase selectively inhibited PDGF-stimulated cell ruffl ing and matrix contraction, whereas blocking Gα i selectively inhibited LPA-stimulated ruffl ing and contraction.
As previously stated, PAK1-regulation of the actin dynamics required for fi broblast ruffl ing can be controlled at the level of ADF/cofi lin phosphorylation by the PAK1 effector LIM kinase (Arber et al., 1998; Yang et al., 1998; Bamburg, 1999; Edwards et al., 1999) . We found that LPA and PDGF both stimulated cofi lin1 phosphorylation, and that stimulation was blocked in PAK1-silenced cells. Moreover, silencing cofi lin1 with siRNA blocked LPA-and PDGF-dependent matrix contraction, as well as membrane ruffl ing. Therefore, we suggest that matrix contraction requires cellular ruffl ing activity stimulated by PAK1 and cofi lin1. Although LIM kinase is the likely intermediate between PAK1 and cofi lin1, we have not succeeded in developing conditions using siRNA to effectively silence LIM kinase expression and directly test its role.
On collagen-coated coverslips, PAK1-silenced fi broblasts showed markedly decreased migration, but cells spread normally and increased formation of lamellipodia after PDGF stimulation. That PAK1-silenced cells formed normal lamellipodia in 2D culture, but lacked ruffl es in 3D matrices, suggests were harvested and used to prepare fl oating collagen matrices. Samples were incubated for the times shown in DME containing 5 mg/ml BSA and 50 ng/ml PDGF or 10 μM LPA, as indicated. At the end of the incubations, extracts of the samples were prepared and subjected to immunoblotting with antibodies directed against phospho-cofi lin1 and tubulin. (B) Cells were transfected for 36 h with 500 nM of cofi lin1 siRNA or sense RNA only (Mock) and then cultured an additional 24 h in growth medium without siRNA. Extracts were prepared and subjected to SDS-PAGE and immunoblotted to analyze levels of cofi lin1 (arrow) and tubulin. (C) Nontransfected (CTL), cofi lin1-silenced, and mock-transfected cells were harvested and used to prepare fl oating collagen matrices. Samples were incubated for 4 h in DME with 5 mg/ml BSA and 50 ng/ml PDGF or 10 μM LPA added as shown. At the end of the incuba-tions, samples were fi xed and the extent of matrix contraction was meas-ured as the decrease in matrix diameter. Data shown are arithmetic means ± SD for three separate experiments.
that lamellipodia and ruffl es may be regulated independently; PAK-independent mechanisms of cell ruffl ing and lamellipodia formation have been previously described (Joneson et al., 1996; Westwick et al., 1997) . Differences in fi broblast adhesion to 3D matrices versus 2D coverslips may also be important. Besides LIM kinase, regulation of ADF/cofi lin and fi broblast ruffl ing can be controlled by integrin interactions and testicular protein kinase 1 (Toshima et al., 2001; LaLonde et al., 2005) . Cells interacting with 3D matrices have fewer stress fi bers, smaller focal adhesions, and decreased activation of focal adhesion kinase compared with cells in 2D culture (Cukierman et al., 2002; Grinnell, 2003; Wozniak et al., 2004) . It is possible, therefore, that in 3D matrices fi broblasts become completely dependent on the PAK1 pathway, whereas human fi broblasts on 2D collagen-coated surfaces can regulate cell ruffl ing and lamellipodia formation by multiple mechanisms.
Also noteworthy is the discovery that the dendritic extensions of PAK1-silenced fi broblasts in 3D matrices showed decreased expansion in response to PDGF. This decrease may have resulted from an increase in microtubule catastrophe in the absence of PAK1 (Wittmann et al., 2003 (Wittmann et al., , 2004 ) because microtubules were shown to be required for formation of the fi broblast dendritic network .
Based on molecular architecture, PAKs can be categorized into two subgroups with three members each (Jaffer and Chernoff, 2002; Bokoch, 2003; Zhao and Manser, 2005) . The group Ι PAKs, including PAK1, share a high degree of amino acid homology and infl uence diverse cellular processes, such as cellular morphology, migration, and gene regulation. Our results identify PAK1 as the major isoform involved in regulation of fi broblast ruffl ing in 3D collagen matrices and collagen matrix contraction, although expression of PAK2 is at least fi ve times higher than PAK1 in human fi broblast based on Western blotting results.
Structurally, the major differences between PAK1 and -2 are in the NH 2 -terminal regulatory domain in which PAK1 has fi ve proline-rich Src homology 3 (SH3)-binding motifs, compared with two SH motifs in PAK2 (Bokoch, 2003) . It has been reported that phosphorylation of the threonine 212 residue in one of PAK1's unique SH3 motifs is important for regulation of neuronal growth cone dynamics (Rashid et al., 2001) . Whether phosphorylation at this site is also important in regulation of fi broblast contraction of collagen matrices has yet to be determined. Figure 9 . mDia1 cooperates with PAK1 in LPA regulation of collagen matrix contraction silencing in human fi broblasts. (A) Cells were transfected for 12 h with 700 nM siRNA or sense RNA only (Mock) and cultured an additional 24 h in growth medium without siRNA. Extracts were prepared and subjected to SDS-PAGE and immunoblotted to analyze levels of mDia1 and actin. (B) mDia1-silenced and mock-transfected cells were harvested and used to prepare fl oating collagen matrices. Samples were incubated for 4 h in DME with 5 mg/ml BSA and 50 ng/ml PDGF or 10 μM LPA added as shown. At the end of the incubations, samples were fi xed, and the extent of matrix contraction was measured as the decrease in matrix diameter. Data shown are arithmetic means ± SD for three separate experiments. (C) At the end of the transfection period, mock-and siRNA-transfected cells were incubated in serum-free medium for 36 h, followed by 4 h in DME with 5 mg/ml BSA and 50 ng/ml PDGF or 10 μM LPA added as shown. Stable microtubules were detected as previously described (Gundersen et al., 1994; Cook et al., 1998) . Subsequently, the indicated samples were treated with 2 μM nocodazole for 2 h . After two rinses with microtubule-stabilizing buffer (MSB; 85 mM Pipes, pH 6.9, 1 mM EGTA, 1 mM MgCl 2 , 2 M glycerol, 1 μg/ml leupeptin, 1 μg/ml pepstatin A, and 1 mM 4-(2-aminoethyl)-benzenesulfonyl fl uoride), samples were treated with 1 ml of MSB containing 200 μg/ml saponin for 5 min at 37°C to extract tubulin monomer, rinsed with MSB, and fi xed with methanol (−20°C) for 10 min, and then stained with anti-tubulin antibody. Bar, 50 μm. Model showing convergence of PDGF and LPA signaling on PAK1 and cofi lin1, cell ruffl ing, and collagen matrix contraction. Rho kinase cooperates with PAK1 for PDGF-stimulated contraction, whereas mDia1 cooperates with PAK1 for LPA-stimulated contraction. Rho kinase also is required for LPA-stimulated retraction of dendritic extensions.
Although Fig. 10 shows PDGF and LPA converging separately on PAK1, Rac is likely to be immediately upstream of PAK1. Preliminary studies showed that dominant-negative expression of N17Rac1, but not of N17Cdc42, completely abolished the formation of dendritic extensions (unpublished data), which was a phenotype more pronounced than observed by knocking down PAK1. Given the potential for indirect effects by overexpression of dominant-negative Ras family mutants (Feig, 1999) , coupled with the diffi culty of transfecting genes into early passage human fi broblasts, our initial results cannot yet be clearly interpreted.
During collagen matrix contraction, individual collagen fi brils are translocated toward the cell surface (Grinnell and Lamke, 1984; Yamato et al., 1995; Tamariz and Grinnell, 2002) . Such translocation of collagen fi brils, when it involves fi broblasts on 2D coverslips, requires a mechanism of contractile force generation (Meshel et al., 2005) . In the case of cell migration, PAK1-dependent cell ruffl ing is usually thought to be important for cells to reach forward (Jaffer and Chernoff, 2002; Bokoch, 2003) , whereas the small G protein Rho has been implicated in generation of contractile force required for cell translocation (Webb et al., 2002; Ridley et al., 2003) .
This study builds on our previous fi nding that Rho was required for fl oating matrix contraction to show that different Rho effectors are involved in contraction dependent on the agonist (i.e., Rho kinase in the case of PDGF and mDia1 in the case of LPA). Because blocking Rho kinase or silencing mDia1 using siRNA inhibited contraction selectively, and neither treatment blocked cell ruffl ing, we propose that the Rho effectors act in parallel to and cooperatively with the PAK1 signaling pathway and play a role in the force generation required for matrix contraction.
At this time we can only speculate as to why LPA requires mDia1 rather than Rho kinase for fl oating matrix contraction. Certainly, LPA activates Rho kinase in these cells because blocking Rho kinase has been shown to inhibit retraction of dendritic extensions without preventing matrix contraction (Abe et al., 2003; Lee et al., 2003) . Rho and Rho kinase have been implicated in myosin II-dependent force generation (Etienne-Manneville and Hall, 2002; Riento and Ridley, 2003) . The role of mDia1 in force generation is less clear, however (Watanabe et al., 1999; Geiger and Bershadsky, 2001 ). Significantly, mDia1 has been implicated in the stabilization of both microtubules (Palazzo et al., 2004) and actin fi laments (Watanabe and Higashida, 2004) , and microtubule dynamics (Dogterom et al., 2005; Grishchuk et al., 2005) as well as microfi lament depolymerization (Mogilner and Oster, 2003) have the potential to generate force independently of actomyosin.
Materials and methods
Materials DME and trypsin/EDTA solution were obtained from Invitrogen. BSA (fatty acid free) and LPA were obtained from Sigma-Aldrich. Vitrogen 100 collagen was obtained from Cohesion Technologies, Inc. PDGF (BB isotype) was obtained from Upstate Biotechnology. LY294002, pertussis toxin, and Y27632 were obtained from Calbiochem-Novabiochem. Total PAK-(C-19), PAK1-(N-20), cofi lin1-, phospho-cofi lin1-(mSer 3), and mDia1-specifi c antibodies were obtained from Santa Cruz Biotechnology, Inc.
rhodamine-B-isothiocyanate-conjugated phalloidin, oligofectamine, and Opti-MEM Ι were obtained from Invitrogen.
Cell culture
Human foreskins were obtained from anonymous donors and provided by the University of Texas Southwestern Medical Center. Fibroblasts from human foreskin specimens (<10th passage) were maintained in 75-cm 2 tissue culture fl asks (Falcon) in DME supplemented with 10% FBS. Fibroblasts were harvested from monolayer culture with 0.25% trypsin/EDTA for 4 min at 37°C, followed by 10% FBS in DME. All incubations with cells were performed at 37°C in a humidifi ed incubator with 5% CO 2 .
For experiments with collagen matrices, cells in neutralized solutions of 1.5 mg/ml of collagen were prewarmed to 37°C for 3-4 min, and 0.2-ml aliquots were placed in 24-well culture plates (Corning). Unless otherwise specifi ed, cell density was 2 × 10 5 cells/matrix for matrix contraction and immunoblotting experiments and 2 × 10 4 cells/matrix for observing cell morphology. Each aliquot of collagen matrix occupied an area outlined by a 12-mm diam circular score within a well. After polymerization for 60 min, matrices were gently released from the underlying culture dishes with a spatula and allowed to fl oat in 0.5 ml of basal medium (DME containing 5 ml/ml BSA). Growth factors and inhibitors were added at the times indicated in the fi gure legend.
For experiments with collagen-coated surfaces, harvested cells (2 × 10 4 ) were incubated for the times indicated in the fi gure legend on 12-mm 2 glass coverslips. The coverslips were coated for 20 min with 50 μg/ml collagen and then rinsed with Dulbecco's PBS (1 mM CaCl 2 , 0.5 mM MgCl 2 , 150 mM NaCl, 3 mM KCl, 1 mM KH 2 PO 4 , and 6 mM Na 2 HPO 4 , pH 7.2). Subsequently, the cultures were incubated with 1 ml DME containing 5 mg/ml BSA and growth factors or inhibitors as indicated in the fi gure legend.
PAK1, cofi lin1, and mDia1 gene silencing
To knock down PAK1, cofi lin1, and mDia1 expression in human fi broblasts, the following primer pairs for siRNA were designed and obtained from the University of Texas Southwestern Medical Center siRNA core facility. PAK1 siRNA: 5′-A A C A C A C A A U U C A U G U C G G T T -3′ and 5′-A A C C G A C A U G A-A U U G U G U G T T -3′. Cofi lin1 siRNA: 5′-G C G G U G C U C U U C U G C C U G A-U U -3′and 5′-U C A G G C A G A A G A G C A C C G C U U -3′. mDia1 siRNA: 5′-A U U C U U C U G C A U C A U A U G G T T -3′ and 5′-C C A U A U G A U G C A G A A G-A A U T T -3′. For annealing, 20 μM of each single-strand 21-nt RNA was incubated in annealing buffer (100 mM potassium acetate, 30 mM Hepes-KOH, pH 7.4, and 2 mM magnesium acetate) for 2 min at 95°C, followed by 2 h at 37°C. To accomplish high effi ciency transfection, fi broblast cultures (60-70% confl uent) were rinsed with antibiotic-free DME and treated with trypsin-EDTA for 1 min to elicit cell rounding, but not detachment. Subsequently, antibiotic-free 10% FBS/DME was added at a ratio of 4:1 to quench the trypsinization. After cells were rinsed with antibiotic-free DME, they were incubated with Opti-MEM I containing 700 nM siRNA-(PAK1 and mDia1) or 500nM siRNA-(cofi lin1) annealed oligonucleotides. After 12 (PAK1 and mDia1) or 36 h (cofi lin1), the transfection medium was removed and replaced with 10% FBS/DME containing antibiotics for an additional 24 h, at which time cells were subcultured. Mock-transfected cells were treated with only the sense direction oligonucleotide at double the concentration.
Cell migration assay
To measure 2D migration, mock-and PAK1-silenced fibroblasts were incubated overnight on collagen-coated coverslips with DME containing 5 mg/ml BSA and 0.1% FBS. The cell cultures were scrape wounded with a pipette tip and then incubated in DME containing 5 mg/ml BSA and 50 ng/ml PDGF.
Fluorescence microscopy
For immunostaining, collagen matrix samples were fi xed for 10 min with 3% paraformaldehyde in PBS (3 mM KCl, 1 mM KH 2 PO 4 , 150 mM NaCl, and 6 mM Na 2 HPO 4 , pH 7.2.) at room temperature, blocked with 2% BSA/1% glycine in PBS for 30 min, and permeabilized for 15 min with 0.5% Triton X-100 in PBS. Samples were then incubated for 1 h at 37°C with mouse anti-β-tubulin (1:100 dilution in 1% BSA/PBS) followed by 45 min at 37°C with FITC-conjugated goat anti-mouse IgG. For actin staining, samples were incubated with Alexa Fluor 594-conjugated phalloidin (1:200 dilution in 1% BSA/PBS) for 30 min at 37°C. Samples were mounted on glass slides with Fluoromount G. (Southern Biotechnology Associates, Inc.) Images were collected using a fl uorescent microscope (Eclipse 400; Nikon) using 10×/0.45, 20×/0.75, and 40×/0.75 infi nity corrected objectives (Plan Apo; Nikon). Images were collected at room temperature using a camera (SenSys; Photometrics) and MetaView acquisition software (Universal Imaging Corp.). Subsequent image processing was performed using Photoshop 5.5 or 7.0 (Adobe) in accordance with the Journal of Cell Biology image acquisition and manipulation instructions.
